Loading publications…
The last 5 uploaded publications
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial
Patrick W. Serruys, Bernard Chevalier, Dariusz Dudek, Ángel Cequier, Didier Carrié, Andrés Íñiguez, Marcello Dominici, René J. van der Schaaf, Michael Haude, Luc Wasungu, Susan Veldhof, Lei Peng, Peter Stæhr, Maik J. Grundeken, Yuki Ishibashi, Héctor M. García‐García, Yoshinobu Onuma (2014). A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial. The Lancet, 385(9962), pp. 43-54, DOI: 10.1016/s0140-6736(14)61455-0.
Article146 days agoComparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial
Patrick W. Serruys, Bernard Chevalier, Yohei Sotomi, Ángel Cequier, Didier Carrié, Jan J. Piek, Ad J. van Boven, Marcello Dominici, Dariusz Dudek, Dougal McClean, Steffen Helqvist, Michael Haude, Sebastian Reith, Manuel Almeida, Gianluca Campo, Andrés Íñiguez, Manel Sabaté, Stephan Windecker, Yoshinobu Onuma (2016). Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial. The Lancet, 388(10059), pp. 2479-2491, DOI: 10.1016/s0140-6736(16)32050-5.
Article146 days agoEverolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial
Manel Sabaté, Ángel Cequier, Andrés Íñiguez, Antonio Serra, Rosana Hernández‐Antolín, Vicente Mainar, Marco Valgimigli, Maurizio Tespili, Pieter den Heijer, Armando Bethencourt, Nicolás Vazquez, Joan Antoni Gómez‐Hospital, José Antonio Baz, Victoria Martín‐Yuste, Robert‐Jan van Geuns, Fernándo Alfonso, Pascual Bordes, Matteo Tebaldi, Mónica Masotti, Antonio Silvestro, Bianca Backx, Salvatore Brugaletta, Gerrit Anne van Es, Patrick W. Serruys (2012). Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial. The Lancet, 380(9852), pp. 1482-1490, DOI: 10.1016/s0140-6736(12)61223-9.
Article146 days agoClinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study
Javier Escaned, Carlos Collet, Nicola Ryan, Giovanni Luigi De Maria, Simon Walsh, Manel Sabaté, Justin E. Davies, Maciej Lesiak, Raúl Moreno, Ignacio Cruz‐González, Stephan P Hoole, Nick E.J. West, Jan J. Piek, Azfar Zaman, Farzin Fath‐Ordoubadi, Rod Stables, Clare Appleby, Nicolas M. Van Mieghem, Robert J. Van Geuns, Neal Uren, Javier Zueco, Paweł Buszman, Andrés Íñiguez, Javier Goicolea, David Hildick‐Smith, Andrzej Ochała, Dariusz Dudek, Colm G. Hanratty, Rafael Cavalcante, A. Pieter Kappetein, David P. Taggart, Gerrit‐Anne van Es, Marie‐Angèle Morel, Ton de Vries, Yoshinobu Onuma, Vasim Farooq, Patrick W. Serruys, Adrian Banning (2017). Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study. European Heart Journal, 38(42), pp. 3124-3134, DOI: 10.1093/eurheartj/ehx512.
Article146 days agoEverolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction—TROFI II trial
Manel Sabaté, Stephan Windecker, Andrés Íñiguez, Lisette Okkels Jensen, Ángel Cequier, Salvatore Brugaletta, Sjoerd H. Hofma, Lorenz Räber, Evald Høj Christiansen, Maarten J. Suttorp, Thomas Pilgrim, Gerrit Anne van Es, Yohei Sotomi, Héctor M. García‐García, Yoshinobu Onuma, Patrick W. Serruys (2015). Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction—TROFI II trial. European Heart Journal, 37(3), pp. 229-240, DOI: 10.1093/eurheartj/ehv500.
Article146 days ago